MELISSA VANCE: Open Payments
NPI 1194798603 · ASHTABULA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,788 in 154 payments from 18 companies in 2025. Trend: 2023 $2,598 · 2024 $4,603 · 2025 $2,788
Food & beverage: $2,781Education: $7
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $660 |
| Regeneron Healthcare Solutions, Inc. | 13 | $325 |
| LEO Pharma Inc. | 15 | $307 |
| Lilly USA, LLC | 13 | $272 |
| Galderma Laboratories, L.P. | 19 | $214 |
| UCB, Inc. | 14 | $193 |
| Novartis Pharmaceuticals Corporation | 9 | $189 |
| PFIZER INC. | 18 | $178 |
| GENZYME CORPORATION | 4 | $106 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $94 |
Products named: SKYRIZI, DUPIXENT, RINVOQ, ADBRY, Bimzelx, CIBINQO, EBGLYSS, LIBTAYO.
Industry payments across OH — which companies pay providers there.
